(Q57803547)

English

Blocking immunoinhibitory receptor LILRB2 reprograms tumor-associated myeloid cells and promotes antitumor immunity

journal article published in 2018

  • Blocking immunoinhibitory receptor LILRB2 reprograms tumor-associated myeloid cells and promotes antitumor immunity.

Statements

Blocking immunoinhibitory receptor LILRB2 reprograms tumor-associated myeloid cells and promotes antitumor immunity (English)
1 reference
1 reference
Icahn School of Medicine at Mount Sinai, New York
1 reference
2 February 2024

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit